This dataset includes simulated datasets generated with the gene expression simulator GeneNetWeaver. The datasets ranged from 20 to 100 genes. Each network size had 50 datasets generated from five different networks, with the first three networks extracted from the Escherichia coli network and the next two networks from the Saccharomyces cerevisiae cell-cycle network.

(A) Bioinformatics Summary statistics and (B) Sequence identity matrix between strains. (XLSX)

This dataset contains the simulated data from a Cox's proportional hazards model with sample size n=250 and number of predictors p=1,000. Survival times were simulated from a Cox's model with the baseline hazard function drawn from a Weibull distribution with a shape parameter 10 and a scale parameter 1. The censoring times were generated randomly to achieve censoring rate of 50%.

Case 1: Markov Chain The location of non-zero coefficients were generated from a Markov chain with the following probabilities: P(beta_1 = 0) = 0.50, P(beta_{j+1} = 0 | \beta_{j} = 0) = 0.99, P(beta_{j+1} = 0 | \beta_{j} ≠ 0) = 0.50. The location of non-zero coefficients were assumed to be the same across all 100 datasets but the effect sizes of those non-zero coefficients were randomly drawn from Uniform(0.5,5). The covariates were generated from AR(1) with different value of rho=0,0.5, and 0.9.

Case 2: Network simulation Gene expression data within an assumed network were simulated. The network consisted of ten disjoint pathways. Each of which contained 100 genes resulting in 1,000 genes in total. Ten regulated genes were assumed in each pathway. The gene expression values were generated from a standard normal distribution. For those regulated genes in the same pathway, the expression values were generated from normal distribution with a correlation rho = 0.7 among those ten regulated pathways. The non-zero coefficients that were drawn from Uniform(0.5, 5).

Financial overview and grant giving statistics of Midsouth Computational Biology and Bioinformatics Society

The bioinformatics market has emerged as a pivotal domain at the intersection of biology and data science, playing an essential role in the analysis and interpretation of complex biological data. As the demand for genomic and proteomic data analysis continues to rise, bioinformatics offers innovative solut...

Financial overview and grant giving statistics of International Society of Big Data and Bioinformatics Inc.

Subtitle

"Synthetic protein dataset with sequences, physical properties, and functional classification for machine learning tasks."

Description

Introduction

This synthetic dataset was created to explore and develop machine learning models in bioinformatics. It contains 20,000 synthetic proteins, each with an amino acid sequence, calculated physicochemical properties, and a functional classification.

Columns Included

• ID_Protein: Unique identifier for each protein.
• Sequence: String of amino acids.
• Molecular_Weight: Molecular weight calculated from the sequence.
• Isoelectric_Point: Estimated isoelectric point based on the sequence composition.
• Hydrophobicity: Average hydrophobicity calculated from the sequence.
• Total_Charge: Sum of the charges of the amino acids in the sequence.
• Polar_Proportion: Percentage of polar amino acids in the sequence.
• Nonpolar_Proportion: Percentage of nonpolar amino acids in the sequence.
• Sequence_Length: Total number of amino acids in the sequence.
• Class: The functional class of the protein, one of five categories: Enzyme, Transport, Structural, Receptor, Other.

Inspiration and Sources

While this is a simulated dataset, it was inspired by patterns observed in real protein datasets, such as: - UniProt: A comprehensive database of protein sequences and annotations. - Kyte-Doolittle Scale: Calculations of hydrophobicity. - Biopython: A tool for analyzing biological sequences.

Proposed Uses

This dataset is ideal for: - Training classification models for proteins. - Exploratory analysis of physicochemical properties of proteins. - Building machine learning pipelines in bioinformatics.

How This Dataset Was Created

1. Sequence Generation: Amino acid chains were randomly generated with lengths between 50 and 300 residues.
2. Property Calculation: Physicochemical properties were calculated using the Biopython library.
3. Class Assignment: Classes were randomly assigned for classification purposes.

Limitations

• The sequences and properties do not represent real proteins but follow patterns observed in natural proteins.
• The functional classes are simulated and do not correspond to actual biological characteristics.

Data Split

The dataset is divided into two subsets: - Training: 16,000 samples (proteinas_train.csv). - Testing: 4,000 samples (proteinas_test.csv).

Acknowledgment

This dataset was inspired by real bioinformatics challenges and designed to help researchers and developers explore machine learning applications in protein analysis.

The size of the Bioinformatics Data Analysis Service market was valued at USD XXX million in 2024 and is projected to reach USD XXX million by 2033, with an expected CAGR of XX% during the forecast period.

snapshot-tab-pane Bioinformatics Market Size 2025-2029The bioinformatics market size is valued to increase by USD 15.98 billion, at a CAGR of 17.4% from 2024 to 2029. Reduction in cost of genetic sequencing will drive the bioinformatics market.Market InsightsNorth America dominated the market and accounted for a 43% growth during the 2025-2029.By Application - Molecular phylogenetics segment was valued at USD 4.48 billion in 2023By Product - Platforms segment accounted for the largest market revenue share in 2023Market Size & ForecastMarket Opportunities: USD 309.88 million Market Future Opportunities 2024: USD 15978.00 millionCAGR from 2024 to 2029 : 17.4%Market SummaryThe market is a dynamic and evolving field that plays a pivotal role in advancing scientific research and innovation in various industries, including healthcare, agriculture, and academia. One of the primary drivers of this market's growth is the rapid reduction in the cost of genetic sequencing, making it increasingly accessible to researchers and organizations worldwide. This affordability has led to an influx of large-scale genomic data, necessitating the development of sophisticated bioinformatics tools for Next-Generation Sequencing (NGS) data analysis. Another significant trend in the market is the shortage of trained laboratory professionals capable of handling and interpreting complex genomic data.This skills gap creates a demand for user-friendly bioinformatics software and services that can streamline data analysis and interpretation, enabling researchers to focus on scientific discovery rather than data processing. For instance, a leading pharmaceutical company could leverage bioinformatics tools to optimize its drug discovery pipeline by analyzing large genomic datasets to identify potential drug targets and predict their efficacy. By integrating these tools into its workflow, the company can reduce the time and cost associated with traditional drug discovery methods, ultimately bringing new therapies to market more efficiently. Despite its numerous benefits, the market faces challenges such as data security and privacy concerns, data standardization, and the need for interoperability between different software platforms.Addressing these challenges will require collaboration between industry stakeholders, regulatory bodies, and academic institutions to establish best practices and develop standardized protocols for data sharing and analysis.What will be the size of the Bioinformatics Market during the forecast period?Get Key Insights on Market Forecast (PDF) Request Free SampleBioinformatics, a dynamic and evolving market, is witnessing significant growth as businesses increasingly rely on high-performance computing, gene annotation, and bioinformatics software to decipher regulatory elements, gene expression regulation, and genomic variation. Machine learning algorithms, phylogenetic trees, and ontology development are integral tools for disease modeling and protein interactions. cloud computing platforms facilitate the storage and analysis of vast biological databases and sequence datas, enabling data mining techniques and statistical modeling for sequence assembly and drug discovery pipelines. Proteomic analysis, protein folding, and computational biology are crucial components of this domain, with biomedical ontologies and data integration platforms enhancing research efficiency.The integration of gene annotation and machine learning algorithms, for instance, has led to a 25% increase in accurate disease diagnosis within leading healthcare organizations. This trend underscores the importance of investing in advanced bioinformatics solutions for improved regulatory compliance, budgeting, and product strategy.Unpacking the Bioinformatics Market LandscapeBioinformatics, an essential discipline at the intersection of biology and computer science, continues to revolutionize the scientific landscape. Evolutionary bioinformatics, with its molecular dynamics simulation and systems biology approaches, enables a deeper understanding of biological processes, leading to improved ROI in research and development. For instance, next-generation sequencing technologies have reduced sequencing costs by a factor of ten, enabling genome-wide association studies and transcriptome sequencing on a previously unimaginable scale. In clinical bioinformatics, homology modeling techniques and protein-protein interaction analysis facilitate drug target identification, enhancing compliance with regulatory requirements. Phylogenetic analysis tools and comparative genomics studies contribute to the discovery of novel biomarkers and the development of personalized treatments. Bioimage informatics and proteomic data integration employ advanced sequence alignment algorithms and fun

Bioinformatics summary data showing the number of genes within each QTL with potential protein-coding changes that are also expressed in mouse eyes.

Bioinformatics, the application of computational tools to the management and analysis of biological data, has stimulated rapid research advances in genomics through the development of data archives such as GenBank, and similar progress is just beginning within ecology. One reason for the belated adoption of informatics approaches in ecology is the breadth of ecologically pertinent data (from genes to the biosphere) and its highly heterogeneous nature. The variety of formats, logical structures, and sampling methods in ecology create significant challenges. Cultural barriers further impede progress, especially for the creation and adoption of data standards. Here we describe informatics frameworks for ecology, from subject-specific data warehouses, to generic data collections that use detailed metadata descriptions and formal ontologies to catalog and cross-reference information. Combining these approaches with automated data integration techniques and scientific workflow systems will maximize the value of data and open new frontiers for research in ecology.

Growth Yield original raw and normalized datasets

Bioinformatics in Healthcare Market Outlook

According to our latest research, the global bioinformatics in healthcare market size reached USD 12.4 billion in 2024, reflecting robust adoption across clinical, research, and pharmaceutical domains. The market is expected to expand at a CAGR of 13.2% from 2025 to 2033, reaching a projected value of USD 36.6 billion by 2033. This impressive growth trajectory is fueled by escalating investments in genomics, rising demand for personalized medicine, and the integration of advanced computational tools in healthcare. The bioinformatics in healthcare market is witnessing a paradigm shift as organizations increasingly leverage data-driven insights to accelerate drug discovery, improve diagnostics, and enhance patient outcomes.

A primary driver for the rapid expansion of the bioinformatics in healthcare market is the surging volume of biological and clinical data being generated worldwide. The proliferation of next-generation sequencing (NGS) technologies, coupled with decreasing costs of genome sequencing, has resulted in an unprecedented influx of genetic information. This wealth of data demands sophisticated bioinformatics solutions to manage, analyze, and interpret complex datasets efficiently. As a result, healthcare institutions, research centers, and pharmaceutical companies are investing heavily in advanced bioinformatics platforms and software to unlock actionable insights from vast genomic and proteomic repositories. This trend is further amplified by the growing recognition of the pivotal role bioinformatics plays in bridging the gap between raw biological data and clinical application.

Another significant growth factor is the expanding application of bioinformatics in personalized medicine and targeted therapeutics. With the healthcare industry shifting towards precision medicine, there is an urgent need for tools that can integrate and analyze multi-omics data—spanning genomics, transcriptomics, proteomics, and metabolomics. Bioinformatics enables the identification of disease biomarkers, prediction of drug responses, and customization of treatment regimens based on individual patient profiles. This has not only improved patient outcomes but has also optimized healthcare resource utilization. The increasing prevalence of chronic diseases, rising cancer incidence, and the demand for tailored therapies are propelling the adoption of bioinformatics in clinical diagnostics and drug development, thus driving overall market growth.

Strategic collaborations and investments by government agencies, academic institutions, and private enterprises are further catalyzing the bioinformatics in healthcare market. Initiatives such as the Human Genome Project and various national genomics programs have laid the foundation for large-scale data generation and sharing. Governments across North America, Europe, and Asia Pacific are launching funding programs to support bioinformatics infrastructure, skill development, and research. These efforts are enhancing data interoperability, standardization, and integration, thereby fostering innovation in the field. Moreover, the emergence of cloud-based bioinformatics platforms is democratizing access to computational resources, enabling smaller organizations and developing regions to participate in cutting-edge research and clinical applications.

From a regional perspective, North America continues to dominate the bioinformatics in healthcare market, accounting for the largest revenue share in 2024. This leadership position is attributed to the presence of advanced healthcare infrastructure, significant R&D investments, and a strong ecosystem of academic and commercial players. Europe follows closely, driven by robust government support and a vibrant biotech sector. Meanwhile, Asia Pacific is emerging as the fastest-growing region, fueled by expanding healthcare expenditure, increasing adoption of genomic medicine, and a burgeoning talent pool in computational biology. Latin America and the Middle East & Africa are also experiencing steady growth, supported by improving healthcare systems and international collaborations.

Solution Analysis

The bioinformatics in healthcare market is segmented by solution into software, services, and platforms, each playing a critical role in the ecosystem. Bioinformatics software forms the backbone of data analysis, enabling researchers and clinicians to process and interpret complex biologi

The bioinformatics market, valued at USD 15,135.48 million in 2023, is expected to grow at a steady CAGR of 10.2%, reaching USD 32,663.77 million by 2031. Asia-Pacific is forecasted to grow at the fastest CAGR of 10.9%.

The global Biological Data Analysis Services market is booming, driven by personalized medicine and advancements in bioinformatics. Explore market size, growth trends, key players (Profacgen, CD ComputaBio, Eurofins Scientific), and regional analysis (North America, Europe, Asia-Pacific) in this comprehensive report covering biomarker identification, biological modeling, and more. Discover future projections and investment opportunities in this rapidly evolving field.

Open data science and algorithm development competitions offer a unique avenue for rapid discovery of better computational strategies. We highlight three examples in computational biology and bioinformatics research in which the use of competitions has yielded significant performance gains over established algorithms. These include algorithms for antibody clustering, imputing gene expression data, and querying the Connectivity Map (CMap). Performance gains are evaluated quantitatively using realistic, albeit sanitized, data sets. The solutions produced through these competitions are then examined with respect to their utility and the prospects for implementation in the field. We present the decision process and competition design considerations that lead to these successful outcomes as a model for researchers who want to use competitions and non-domain crowds as collaborators to further their research.

Disclaimer

This is a data set of mine that I though might be enjoyable to the community. It's concerning Next generation sequencing and Transcriptomics. I used several raw datasets, that are public, but the processing to get to this dataset is extensive. This is my first contribution to kaggle, so be nice, and let me know how I can improve the experience. NGS machines are combined the biggest data producer worldwide. So why not add some (more? ) to kaggle.

A look into Yeast transcriptomics

Background

Yeasts ( in this case saccharomyces cerevisiae) are used in the production of beer, wine, bread and a whole lot of Biotech applications such as creating complex pharmaceuticals. They are living eukaryotic organisms (meaning quite complex). All living organisms store information in their DNA, but action within a cell is carried out by specific Proteins. The path from DNA to Protein (from data to action) is simple. a specific region on the DNA gets transcribed to mRNA, that gets translated to proteins. Common assumption says that the translation step is linear, more mRNA means more protein. Cells actively regulate the amount of protein by the amount of mRNA it creates. The expression of each gene depends on the condition the cell is in (starving, stressed etc..) Modern methods in Biology show us all mRNA that is currently inside a cell. Assuming the linearity of the process, we can get more protein the more specific mRNA is available to a cell. Making mRNA an excellent marker for what is actually happening inside a cell. It is important to consider that mRNA is fragile. It is actively replenished only when it is needed. Both mRNA and proteins are expensive for a cell to produce .

Yeasts are good model organisms for this, since they only have about 6000 genes. They are also single cells which is more homogeneous, and contain few advanced features (splice junctions etc.)

( all of this is heavily simplified, let me know if I should go into more details )

The data

files

The following files are provided **SC_expression.csv** expression values for each gene over the available conditions **labels_CC.csv ** labels for the individual genes , their status and where known intracellular localization ( see below) Maybe this would be nice as a little competition, I'll see how this one is going before I'll upload the other label files. Please provide some feedback on the presentation, and whatever else you would want me to share.

background

I used 92 samples from various openly available raw datasets, and ran them through a modern RNAseq pipeline. Spanning a range of different conditions (I hid the raw names). The conditions covered stress conditions, temperature and heavy metals, as well as growth media changes and the deletion of specific genes. Originally I had 150 sets, 92 are of good enough quality. Evaluation was done on gene level. Each gene got it's own row, Samples are columns (some are in replicates over several columns) . Expression levels were normalized with by TPM (transcripts per million), a default normalization procedure. Raw counts would have been integers, normalized they are floats.

Analysis and labels

Genes

The function of individual genes is a matter of dispute. Clearly living cells are complex. The inner machinations of cells are not visible. Gene functionality is commonly inferred indirectly by removing a gene, and test the cells behavior. This is time consuming and not very precise. As you can see in the dataset, there is still much to be done to fully understand even single cell yeasts.

The provided dataset is allows for a different approach to functional classification of genes. The label files contained in the set correspond a gene to a specific label. The classification is based on the official Gene Onthology associations classification. I simplified the nomenclature. Gene functionality is usually given in a hierarchical structure. [inside cell --> cytoplasma --> associated to complex A ... ] I'm only keeping high level associations, and using readable terms instead of GO terms. I'll extend if people are interested.

Labels

CC labels concern Cellular Component.
Where the gene is within a cell. goes into details of found associations. the term 'cellular_component' should be seen as E.g the label 'cellular_component' is synonymous with 'unknown location' . CC is the easiest label to attach to a gene. It is the one that can be studied the easiest. Still there are many genes missing.

MF labels concern Molecular Function. What is the gene doing. [upcoming] BP labels concern Biological Processes. What is the genes involvement. [upcoming]

The core interest here is whether it is possible to improve the genes classification by modeling the data. A common assu...

Regarding the Proteomics and Bioinformatics Raw Data: The raw and processed data from the proteomics and subsequent bioinformatics analyses are provided to allow for a deeper understanding of the experimental results.This data underpins the statistical comparisons and functional interpretations discussed in the main text, offering transparency and enabling further independent analysis. Regarding the Enrichment Analysis Gene Sets: For the functional enrichment analysis,we utilized gene sets derived from established public databases, including: Gene Ontology (GO)，Kyoto Encyclopedia of Genes and Genomes (KEGG) and so on. The specific gene sets used,along with their source identifiers, are detailed to ensure the clarity and reproducibility of our enrichment findings.

According to Cognitive Market Research, the Global Bioinformatics Services Market Size was USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.

• The global Bioinformatics services Market will expand significantly by XX% CAGR between 2024 and 2031.

• Based on technology, Because of the growing number of platform applications and the need for improved tools for drug development, the bioinformatics platforms segment dominated the market.

• In terms of service type, The sequencing services segment held the largest share and is anticipated to grow over the coming years

• Based on application, The genomic segment dominated the bioinformatics market

• Based on End-user, academic institutes and research centers segment hold the largest share.

• Based on speciality segment, The medical bioinformatics segment holds the large share and is anticipated to expand at a substantial CAGR during the forecast period.

• The North America region accounted for the highest market share in the Global Bioinformatics Services Market. CURRENT SCENARIO OF THE BIOINFORMATICS SERVICES

Driving Factors of the Bioinformatics Services Market

Expansive uses of bioinformatics across multiple sectors is propelling the market's growth.

Several industries, such as the food, bioremediation, agriculture, forensics, and consumer industries, are also using bioinformatics services to improve the quality of their products and supply chain processes. Companies in a variety of sectors are rapidly utilizing bioinformatics services such as data integration, manipulation, lead generation, data management, in silico analysis, and advanced knowledge discovery.

• Bioinformatics Approaches in Food Sciences

In order to meet the needs of food production, food processing, enhancing the quality and nutritional content of food sources, and many other areas, bioinformatics plays a significant role in forecasting and evaluating the intended and undesired impacts of microorganisms on food, genomes, and proteomics research. Furthermore, bioinformatics techniques can be applied to produce crops with high yields and resistance to disease, among other desirable qualities. Additionally, there are numerous databases with information about food, including its components, nutritional value, chemistry, and biology.

Genome Canada is proud to partner with five Institutes where there are five funding pools within this opportunity and Genome Canada is partnering on the Bioinformatics, Computational Biology and Health Data Sciences pool. (Source:https://genomecanada.ca/genome-canada-partners-with-cihr-to-launch-health-research-training-platform-2024-25/)

• Bioinformatics in agriculture

Bioinformatics is becoming more and more crucial in the gathering, storing, and processing of genomic data in the field of agricultural genomics, or agri-genomics. Generally referred to as agri-informatics, some of the various applications of bioinformatics tools and methods in agriculture focus on improving plant resistance against biotic and abiotic stressors as well as enhancing the nutritional quality in depleted soils. Beyond these uses, computer software-assisted gene discovery has enabled researchers to create focused strategies for seed quality enhancement, incorporate extra micronutrients into plants for improved human health, and create plants with phytoremediation potential.

India/UK-based Agri-Genomics startup, Piatrika Biosystems has raised $1.2 Million in a seed round led by Ankur Capital. The company is bringing sustainable seeds and agri chemicals to market faster and cheaper. The investment will be used to build a strong Product Development team, also for more profound research, and to accelerate the productionising and commercialization of MVP. (Source:https://pressroom.icrisat.org/agri-genomics-startup-piatrika-biosystems-raises-12-million-in-seed-funding-led-by-ankur-capital)

This expansion in the application areas of bioinformatics services is likely to drive the overall market growth. Bioinformatics services such as data integration, manipulation, lead discovery, data management, in silico analysis, and advanced knowledge discovery are increasingly being adopted by companies across various industries. ...

Financial overview and grant giving statistics of Phoenix Bioinformatics Corporation